Bvf-Incil

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AXSM",
  "FBRX",
  "NAMS",
  "RVMD",
  "GLPG",
  "TCRX",
  "ANNX",
  "OLMA",
  "GPCR",
  "MIRM",
  "THRD",
  "TYRA",
  "KYMR",
  "GLUE",
  "ALLK",
  "AVTX",
  "EPIX",
  "OVID",
  "PVLA",
  "RPTX",
  "SABS",
  "SEPN",
  "IONS",
  null,
  "GHRS",
  "MOLN",
  "ZYME",
  "IVA",
  null,
  "RAPT",
  "PTGX",
  "FDMT",
  "TENX",
  "MLTX",
  "ACIU",
  "GLYC",
  "CDTX",
  "ELDN",
  "IMUX",
  "IKNA",
  "ITOS",
  "KURA",
  "VERV",
  "VSTM",
  "VIGL",
  "XOMA",
  "FHTX",
  "XNCR",
  "CELC",
  "CGEM",
  "CTMX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 51
Total Value: 2453567172
Accession Number: 0000921895-25-001528
Form Type: 13F-HR
CIK: bvf-incil
Manager Name: Bvf-Incil

Data Enrichment

96% identified

49 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

51 positions • $2.5B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 3

Sort by:

Forte Biosciences, Inc.

FBRX|34962G208

Shares:594.3K

Value:$4.6M

% of Portfolio:0.2% ($4.6M/$2.5B)

Allakos Inc.

ALLK|01671P100

Shares:16.6M

Value:$3.8M

% of Portfolio:0.2% ($3.8M/$2.5B)

CytomX Therapeutics, Inc.

CTMX|23284F105

Shares:5.2M

Value:$3.3M

% of Portfolio:0.1% ($3.3M/$2.5B)

TENAX THERAPEUTICS, INC.

TENX|88032L605

Shares:339.5K

Value:$2.2M

% of Portfolio:0.1% ($2.2M/$2.5B)

Inventiva S.A.

IVA|46124U107

Shares:686.0K

Value:$2.1M

% of Portfolio:0.1% ($2.1M/$2.5B)

GLYCOMIMETICS INC

GLYC|38000Q102

Shares:9.5M

Value:$2.0M

% of Portfolio:0.1% ($2.0M/$2.5B)

SAB Biotherapeutics, Inc.

SABS|78397T202

Shares:917.8K

Value:$1.2M

% of Portfolio:0.1% ($1.2M/$2.5B)

NewAmsterdam Pharma Co N.V.

NAMS|N62509109

Shares:59.1K

Value:$1.2M

% of Portfolio:0.0% ($1.2M/$2.5B)

Ovid Therapeutics Inc.

OVID|690469101

Shares:3.9M

Value:$1.2M

% of Portfolio:0.0% ($1.2M/$2.5B)

29286M113

Shares:945.4K

Value:$605.1K

% of Portfolio:0.0% ($605.1K/$2.5B)

H57830137

Shares:143.7K

Value:$221.3K

% of Portfolio:0.0% ($221.3K/$2.5B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Forte Biosciences, Inc.(FBRXcusip34962G208)	594.3K	QoQ 0.00% (-0) YoY NEW(+594.3K)	All Managers (Combined)	$4.6M	0.2% ($4.6M/$2.5B)	QoQ -65.83% (-$8.9M) YoY NEW(+$4.6M)
Allakos Inc.(ALLKcusip01671P100)	16.6M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$3.8M	0.2% ($3.8M/$2.5B)	QoQ -81.19% (-$16.3M) YoY -81.93% (-$17.1M)
CytomX Therapeutics, Inc.(CTMXcusip23284F105)	5.2M	QoQ 0.00% (-0) YoY -20.73% (-1.4M)	All Managers (Combined)	$3.3M	0.1% ($3.3M/$2.5B)	QoQ -38.27% (-$2.1M) YoY -76.88% (-$11.1M)
TENAX THERAPEUTICS, INC.(TENXcusip88032L605)	339.5K	QoQ 0.00% (+0) YoY NEW(+339.5K)	All Managers (Combined)	$2.2M	0.1% ($2.2M/$2.5B)	QoQ +5.81% (+$122.2K) YoY NEW(+$2.2M)
Inventiva S.A.(IVAcusip46124U107)	686.0K	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$2.1M	0.1% ($2.1M/$2.5B)	QoQ +39.53% (+$583.1K) YoY -17.12% (-$425.3K)
GLYCOMIMETICS INC(GLYCcusip38000Q102)	9.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$2.0M	0.1% ($2.0M/$2.5B)	QoQ -15.66% (-$372.2K) YoY -93.00% (-$26.6M)
SAB Biotherapeutics, Inc.(SABScusip78397T202)	917.8K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.2M	0.1% ($1.2M/$2.5B)	QoQ -64.65% (-$2.3M) YoY -70.26% (-$2.9M)
NewAmsterdam Pharma Co N.V.(NAMScusipN62509109)	59.1K	QoQ NEW(+59.1K) YoY -96.11% (-1.5M)	All Managers (Combined)	$1.2M	0.0% ($1.2M/$2.5B)	QoQ NEW(+$1.2M) YoY -96.64% (-$34.8M)
Ovid Therapeutics Inc.(OVIDcusip690469101)	3.9M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.2M	0.0% ($1.2M/$2.5B)	QoQ -66.59% (-$2.4M) YoY -89.77% (-$10.6M)
(cusip29286M113)✕	945.4K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$605.1K	0.0% ($605.1K/$2.5B)	QoQ -24.71% (-$198.6K) YoY -87.69% (-$4.3M)
(cusipH57830137)✕	143.7K	QoQ 0.00% (-0) YoY NEW(+143.7K)	All Managers (Combined)	$221.3K	0.0% ($221.3K/$2.5B)	QoQ -27.01% (-$81.9K) YoY NEW(+$221.3K)